Ashiya, Japan

Yoshihide Suwa

This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Suntory Holdings Limited. Active years: 2012.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Yoshihide Suwa. Retrieved from https://idiyas.com/inventor/yoshihide-suwa-unbmfj4d

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank


Average Co-Inventor Count = 4.0

ph-index = 1


Company Filing History:


Years Active: 2012

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Inventor Spotlight: Yoshihide Suwa

Introduction

Yoshihide Suwa, an innovative inventor based in Ashiya, Japan, has made significant contributions in the field of pharmacology. With a focus on developing compounds for medical use, his dedication to advancing healthcare solutions has led to the successful creation of a notable patent.

Latest Patents

Suwa holds a patent for a novel compound that functions as an α-adrenergic receptor antagonistic agent. This innovative composition is designed to provide therapeutic effects for treating hypertension and prostatic hypertrophy. The patented compound is represented by the specific formula (1), showcasing the intricacies of his work and its potential impact on patient care.

Career Highlights

Suwa's career is marked by his current role at Suntory Holdings Limited, where he collaborates with a team of dedicated professionals. His contributions to the company underscore his commitment to research and development in the pharmaceutical sector.

Collaborations

Throughout his career, Suwa has had the opportunity to work alongside distinguished colleagues such as Toshiyuki Wakimoto and Haruo Nukaya. Their collaboration has fostered an environment of innovation and creativity, leading to impressive advancements in their shared field.

Conclusion

Yoshihide Suwa is a testament to the power of innovation in medicine. His work in developing effective therapeutic agents represents a crucial step forward in treating prevalent health issues. With his ongoing dedication and collaborative efforts at Suntory Holdings Limited, the future holds great promise for his contributions to healthcare advancements.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…